日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

整合单细胞分析揭示了与实体瘤免疫抑制相关的二分性NK细胞群。

Lozada John R, Ali Atef, Luo Christine, Plagens Rosemary N, Zhang Bin, Elliott Andrew, Boytim Ella, Zorko Nicholas A, Heath Elisabeth I, Patnaik Akash, VanderWalde Ari M, Antonarakis Emmanuel S, Miller Jeffrey S, Hwang Justin H, Cichocki Frank

What About the Caregivers? Music Medicine as a Tool for Improving Psychological Well-Being Among Caregivers During Cancer Chemotherapy Treatment

那么,照顾者们呢?音乐疗法能否作为改善癌症化疗期间照顾者心理健康的工具

Harper, Felicity W K; Moore, Tanina Foster; Heath, Allison S; Kim, Seongho; Heath, Elisabeth I

Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer

FOR46 (FG-3246) 是一种靶向 CD46 的免疫调节抗体药物偶联物,用于治疗转移性去势抵抗性前列腺癌患者,这是一项 I 期首次人体研究。

Aggarwal, Rahul R; Vuky, Jacqueline; VanderWeele, David; Rettig, Matthew; Heath, Elisabeth I; Quigley, David; Huang, Jiaoti; Chumber, Arun; Cheung, Alexander; Foye, Adam; Leung, Stanley; Abbey, Jill; Dorr, Andrew; Nasoff, Marc; Hunter, John; Wang, Steven; Flavell, Robert R; Fong, Lawrence; Liu, Bin; Small, Eric J

Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

基于结构导向的FOXA1改变分类可识别具有相反临床结果和不同分子及免疫学亚型的前列腺癌

Hwang, Justin; Likasitwatanakul, Pornlada; Deshmukh, Sachin Kumar; Wu, Sharon; Kwon, Jason J; Toye, Eamon; Moline, David; Evans, Mark G; Elliott, Andrew; Passow, Rachel; Luo, Christine; John, Emily; Gandhi, Nishant; McKay, Rana R; Heath, Elisabeth I; Nabhan, Chadi; Reizine, Natalie; Orme, Jacob J; Domingo Domenech, Josep M; Sartor, Oliver; Baca, Sylvan C; Dehm, Scott M; Antonarakis, Emmanuel S

Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

对 16,812 例晚期癌症患者的血浆游离 DNA 变异体进行表征,以确定其是肿瘤来源还是克隆性造血来源

Magee Daniel, Domenyuk Valeriy, Abraham Jim, Perdigones Borderias Nieves, Swensen Jeff, Solipuram Praveena, Ayanambakkam Adanma, Mehdi Raja, Challagalla Jagathi, Heath Elisabeth, Landsverk Megan, Jurkiewicz Magdalena, Shimkus Brian, Pinto Ian, Patterson Daniel, Hsiehchen David, Koya Supriya, Somer Bradley, Velez Michel, Shields Anthony F, Cultrera Jennifer, Ribeiro Jennifer R, Hahn-Lowry Robert, Sledge George W, Oberley Matthew, Radovich Milan, Spetzler David

Outcomes for [(177)Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer

[(177)Lu]Lu-PSMA-617联合或不联合雄激素受体通路抑制剂治疗转移性去势抵抗性前列腺癌患者的疗效

Muniz, Miguel; Sartor, Oliver; Orme, Jacob J; Koch, Regina M; Scharf, Zachary; Heath, Elisabeth I; Zarka, Jabra G; Kase, Adam M; Riaz, Irbaz B; Andrews, Jack R; Thorpe, Matthew P; Tuba Kendi, A; Bilgin, Gokce Belge; Johnson, Geoffrey B; Kwon, Eugene D; Childs, Daniel S

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes

前列腺癌中自然杀伤细胞浸润预示着患者预后改善

Zorko, Nicholas A; Makovec, Allison; Elliott, Andrew; Kellen, Samuel; Lozada, John R; Arafa, Ali T; Felices, Martin; Shackelford, Madison; Barata, Pedro; Zakharia, Yousef; Narayan, Vivek; Stein, Mark N; Zarrabi, Kevin K; Patnaik, Akash; Bilen, Mehmet A; Radovich, Milan; Sledge, George; El-Deiry, Wafik S; Heath, Elisabeth I; Hoon, Dave S B; Nabhan, Chadi; Miller, Jeffrey S; Hwang, Justin H; Antonarakis, Emmanuel S

Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes

更正:前列腺癌中自然杀伤细胞浸润预示着患者预后改善

Zorko, Nicholas A; Makovec, Allison; Elliott, Andrew; Kellen, Samuel; Lozada, John R; Arafa, Ali T; Felices, Martin; Shackelford, Madison; Barata, Pedro; Zakharia, Yousef; Narayan, Vivek; Stein, Mark N; Zarrabi, Kevin K; Patnaik, Akash; Bilen, Mehmet A; Radovich, Milan; Sledge, George; El-Deiry, Wafik S; Heath, Elisabeth I; Hoon, Dave S B; Nabhan, Chadi; Miller, Jeffrey S; Hwang, Justin H; Antonarakis, Emmanuel S

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now

将普遍的生殖系基因检测纳入前列腺癌患者的标准治疗方案:时不我待

Shore, Neal; Nielsen, Sarah M; Esplin, Edward D; Antonarakis, Emmanuel S; Barata, Pedro C; Beer, Tomasz M; Beltran, Himisha; Bryce, Alan; Cookson, Michael S; Crawford, E David; Dorff, Tanya B; George, Daniel J; Heath, Elisabeth I; Helfand, Brian T; Hussain, Maha; Mckay, Rana R; Morgans, Alicia K; Morris, Michael J; Paller, Channing J; Ross, Ashley E; Sartor, Oliver; Shen, John; Sieber, Paul; Smith, Matthew R; Wise, David R; Armstrong, Andrew J

Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617

接受 177Lu-PSMA-617 治疗的 PSMA 阳性转移性去势抵抗性前列腺癌患者的基因组改变及相关结局

Panian, Justine; Henderson, Nicholas C; Herchenhorn, Daniel; Barata, Pedro C; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S; Jindal, Tanya; Nauseef, Jones T; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T; Raychaudhuri, Ruben; Reichert, Zachery R; Dorff, Tanya; Armstrong, Andrew J; Wang, John; Alva, Ajjai; McKay, Rana R